Abstract
Gingival enlargement is characterized by an increase in the volume of gingival tissues that can be aggravated by local factors. Many drugs are known to induce gingival overgrowth. Physiopathological mechanisms involved in this frequent complication have not yet been totally elucidated. Most often, this increase does not correspond to an increase in the number of fibroblasts or an increase in the volume of fibroblasts, however a tumoral process must systematically be investigated and ruled out.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Bibliography
Agrawal AA. Gingival enlargements: differential diagnosis and review of literature. World J Clin Cases. 2015;3(9):779–88.
Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol Am Acad Periodontol. 1999;4(1):1–6.
Asgary S, Aminzadeh N. Unilateral gingival enlargement in patient with neurofibromatosis type I. N Y State Dent J. 2012;78(6):50–3.
Aslangul E, Gadhoum H, Badoual C, Szwebel T, Perrot S, Le Jeunne C. A chronic gingival hypertrophy. Rev Med Interne. 2009;30(3):260–1.
Barclay S, Thomason JM, Idle JR, Seymour RA. The incidence and severity of nifedipine-induced gingival overgrowth. J Clin Periodontol. 1992;19(5):311–4.
Bekisz O, Darimont F, Rompen EH. Diffuse but unilateral gingival enlargement associated with von Recklinghausen neurofibromatosis: a case report. J Clin Periodontol. 2000;27(5):361–5.
Brown RS, Arany PR. Mechanism of drug-induced gingival overgrowth revisited: a unifying hypothesis. Oral Dis. 2015;21(1):e51–61.
Brown RS, Beaver WT, Bottomley WK. On the mechanism of drug-induced gingival hyperplasia. J Oral Pathol Med. 1991;20(5):201–9.
Calne RY, White DJ. The use of cyclosporin A in clinical organ grafting. Ann Surg. 1982;196(3):330–7.
Cole JA, Warthan MM, Hirano SA, Gowen CW, Williams JV. Scurvy in a 10-year-old boy. Pediatr Dermatol. 2011;28(4):444–6.
Coletta RD, Graner E. Hereditary gingival fibromatosis: a systematic review. J Periodontol. 2006;77(5):753–64.
Cotrim P, Martelli-Junior H, Graner E, Sauk JJ, Coletta RD. Cyclosporin A induces proliferation in human gingival fibroblasts via induction of transforming growth factor-beta1. J Periodontol. 2003;74(11):1625–33.
Dongari-Bagtzoglou A, Research, Science and Therapy Committee, American Academy of Periodontology. Drug-associated gingival enlargement. J Periodontol. 2004;75(10):1424–31.
Fujimori Y, Maeda S, Saeki M, Morisaki I, Kamisaki Y. Inhibition by nifedipine of adherence- and activated macrophage-induced death of human gingival fibroblasts. Eur J Pharmacol. 2001;415(1):95–103.
Gawron K, Łazarz-Bartyzel K, Potempa J, Chomyszyn-Gajewska M. Gingival fibromatosis: clinical, molecular and therapeutic issues. Orphanet J Rare Dis. 2016;11:9.
Gelfand EW, Cheung RK, Mills GB. The cyclosporins inhibit lymphocyte activation at more than one site. J Immunol. 1987;138(4):1115–20.
Graves DT, Li J, Cochran DL. Inflammation and uncoupling as mechanisms of periodontal bone loss. J Dent Res. 2011;90(2):143–53.
Güzel A, Köksal N, Aydın D, Aslan K, Gören F, Karagöz F. A rare clinical presentation of sarcoidosis; gingivitis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;116(4):e280–2.
Hassell TM, Hefti AF. Drug-induced gingival overgrowth: old problem, new problem. Crit Rev Oral Biol. 1991;2(1):103–37.
Heasman PA, Hughes FJ. Drugs, medications and periodontal disease. Br Dent J. 2014;217(8):411–9.
Hou GL, Huang JS, Tsai CC. Analysis of oral manifestations of leukemia: a retrospective study. Oral Dis. 1997;3(1):31–8.
Iacopino AM, Doxey D, Cutler CW, Nares S, Stoever K, Fojt J, et al. Phenytoin and cyclosporine A specifically regulate macrophage phenotype and expression of platelet-derived growth factor and interleukin-1 in vitro and in vivo: possible molecular mechanism of drug-induced gingival hyperplasia. J Periodontol. 1997;68(1):73–83.
Ilgenli T, Atilla G, Baylas H. Effectiveness of periodontal therapy in patients with drug-induced gingival overgrowth. Long-term results. J Periodontol. 1999;70(9):967–72.
Joshi C, Shukla P. Plasma cell gingivitis. J Indian Soc Periodontol. 2015;19(2):221–3.
Jung J-Y, Jeong Y-J, Jeong T-S, Chung H-J, Kim W-J. Inhibition of apoptotic signals in overgrowth of human gingival fibroblasts by cyclosporin A treatment. Arch Oral Biol. 2008;53(11):1042–9.
Kantarci A, Cebeci I, Tuncer O, Carin M, Firatli E. Clinical effects of periodontal therapy on the severity of cyclosporin A-induced gingival hyperplasia. J Periodontol. 1999;70(6):587–93.
Khocht A, Schneider LC. Periodontal management of gingival overgrowth in the heart transplant patient: a case report. J Periodontol. 1997;68(11):1140–6.
Kimball O. The treatment of epilepsy with sodium diphenylhydantoinate. JAMA. 1939;112:1244–5.
Kwon JH, Song JC, Lee SH, Lee SY, Yang CW, Kim YS, et al. Non-Hodgkin’s lymphoma manifest as gingival hyperplasia in a renal transplant recipient. Korean J Intern Med. 2005;20(4):330–4.
Lankarani KB, Sivandzadeh GR, Hassanpour S. Oral manifestation in inflammatory bowel disease: a review. World J Gastroenterol. 2013;19(46):8571–9.
Lederman D, Lumerman H, Reuben S, Freedman PD. Gingival hyperplasia associated with nifedipine therapy. Report of a case. Oral Surg Oral Med Oral Pathol. 1984;57(6):620–2.
Lim H-C, Kim C-S. Oral signs of acute leukemia for early detection. J Periodontal Implant Sci. 2014;44(6):293–9.
Lindhe J, Lang NP, Karring T. Plaque induced gingival diseases. In: Clinical periodontology and implant dentistry. 5th ed. Ames: Blackwell Munksgaard; 2008. p. 405–19.
Lucas RM, Howell LP, Wall BA. Nifedipine-induced gingival hyperplasia. A histochemical and ultrastructural study. J Periodontol. 1985;56(4):211–5.
Mavrogiannis M, Ellis JS, Seymour RA, Thomason JM. The efficacy of three different surgical techniques in the management of drug-induced gingival overgrowth. J Clin Periodontol. 2006b;33(9):677–82.
Mavrogiannis M, Ellis JS, Thomason JM, Seymour RA. The management of drug-induced gingival overgrowth. J Clin Periodontol. 2006a;33(6):434–9.
Maxymiw WG, Wood RE, Lee L. Primary, multi-focal, non-Hodgkin’s lymphoma of the jaws presenting as periodontal disease in a renal transplant patient. Int J Oral Maxillofac Surg. 1991;20(2):69–70.
Mesa FL, Osuna A, Aneiros J, Gonzalez-Jaranay M, Bravo J, Junco P, et al. Antibiotic treatment of incipient drug-induced gingival overgrowth in adult renal transplant patients. J Periodontal Res. 2003;38(2):141–6.
Modéer T, Mendez C, Dahllöf G, Andurén I, Andersson G. Effect of phenytoin medication on the metabolism of epidermal growth factor receptor in cultured gingival fibroblasts. J Periodontal Res. 1990;25(2):120–7.
Moffitt ML, Bencivenni D, Cohen RE. Drug-induced gingival enlargement: an overview. Compend Contin Educ Dent. 2013;34(5):330–6.
Nagpal S, Acharya AB, Thakur SL. Periodontal disease and anemias associated with Crohn’s disease. A case report. N Y State Dent J. 2012;78(2):47–50.
Nakou M, Kamma JJ, Andronikaki A, Mitsis F. Subgingival microflora associated with nifedipine-induced gingival overgrowth. J Periodontol. 1998;69(6):664–9.
Paik J-W, Kim C-S, Cho K-S, Chai J-K, Kim C-K, Choi S-H. Inhibition of cyclosporin A-induced gingival overgrowth by azithromycin through phagocytosis: an in vivo and in vitro study. J Periodontol. 2004;75(3):380–7.
Raut A, Huryn J, Pollack A, Zlotolow I. Unusual gingival presentation of post-transplantation lymphoproliferative disorder: a case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90(4):436–41.
Savage NW, Daly CG. Gingival enlargements and localized gingival overgrowths. Aust Dent J. 2010;55(Suppl 1):55–60.
Seymour RA, Ellis JS, Thomason JM. Risk factors for drug-induced gingival overgrowth. J Clin Periodontol. 2000;27(4):217–23.
Spatafore CM, Keyes G, Skidmore AE. Lymphoma: an unusual oral presentation. J Endod. 1989;15(9):438–41.
Strachan D, Burton I, Pearson GJ. Is oral azithromycin effective for the treatment of cyclosporine-induced gingival hyperplasia in cardiac transplant recipients? J Clin Pharm Ther. 2003;28(4):329–38.
Subramani T, Rathnavelu V, Alitheen NB. The possible potential therapeutic targets for drug induced gingival overgrowth. Mediators Inflamm. 2013;2013:639468.
Thomason JM, Seymour RA, Rice N. The prevalence and severity of cyclosporin and nifedipine-induced gingival overgrowth. J Clin Periodontol. 1993;20(1):37–40.
Tipton DA, Stricklin GP, Dabbous MK. Fibroblast heterogeneity in collagenolytic response to cyclosporine. J Cell Biochem. 1991;46(2):152–65.
Trackman PC, Kantarci A. Molecular and clinical aspects of drug-induced gingival overgrowth. J Dent Res. 2015;94(4):540–6.
Uzel MI, Kantarci A, Hong HH, Uygur C, Sheff MC, Firatli E, et al. Connective tissue growth factor in drug-induced gingival overgrowth. J Periodontol. 2001;72(7):921–31.
Varga E, Lennon MA, Mair LH. Pre-transplant gingival hyperplasia predicts severe cyclosporin-induced gingival overgrowth in renal transplant patients. J Clin Periodontol. 1998;25(3):225–30.
Vogel RI. Gingival hyperplasia and folic acid deficiency from anticonvulsive drug therapy: a theoretical relationship. J Theor Biol. 1977;67(2):269–78.
Williamson MS, Miller EK, Plemons J, Rees T, Iacopino AM. Cyclosporine A upregulates interleukin-6 gene expression in human gingiva: possible mechanism for gingival overgrowth. J Periodontol. 1994;65(10):895–903.
Wilson RF, Morel A, Smith D, Koffman CG, Ogg CS, Rigden SP, et al. Contribution of individual drugs to gingival overgrowth in adult and juvenile renal transplant patients treated with multiple therapy. J Clin Periodontol. 1998;25(6):457–64.
Wong W, Hodge MG, Lewis A, Sharpstone P, Kingswood JC. Resolution of cyclosporin-induced gingival hypertrophy with metronidazole. Lancet Lond Engl. 1994;343(8903):986.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Bontemps, L., Gaultier, F., Anagnostou, F., Ejeil, Al., Dridi, SM. (2021). Drug-Induced Gingival Overgrowth. In: Cousty, S., Laurencin-Dalicieux, S. (eds) Drug-Induced Oral Complications. Springer, Cham. https://doi.org/10.1007/978-3-030-66973-7_2
Download citation
DOI: https://doi.org/10.1007/978-3-030-66973-7_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-66972-0
Online ISBN: 978-3-030-66973-7
eBook Packages: MedicineMedicine (R0)